Containment in a high potent manufacturing facility
Highly potent formulation development in oncology
PCI's automated sterile fill-finish machines now operational
Robotic aseptic processing
CDMOs deliver increased performance for pharma clients with agility and innovation
PCI expands biologics with Midwest “centre of excellence”
Outsourcing your highly potent oncology drug product
Addressing rare disease drug product manufacturing challenges
Cleaning validation and verification in a high potent granulation suite
PCI Pharma Services announces multimillion dollar expansion to UK manufacturing facility
Humanigen and PCI partner to prepare for commercialisation in the UK
PCI Pharma Services announces major manufacturing expansion with $100 million investment in New England
PCI announces clinical centre of excellence in Boston
Biologics and specialty medicines: planning your packaging from clinic to launch (part I)
PCI Pharma expands cold chain supply storage in Berlin
Manufacturing Chemist Live: Day Two Review
